Researchers from MIT and Scripps have unveiled a promising new HIV vaccine approach that generates a powerful immune response ...

A twice-yearly injectable drug for the prevention of HIV infection has been approved by the United States’ Food and Drug ...

On Wednesday, the Food and Drug Administration approved a highly effective, injectable drug to help prevent the transmission ...

A major win in the fight against HIV infections. The Food and Drug Administration approved a new twice-a-year shot to prevent ...

FDA approval paves the way for the jab to roll out across the world. But with funding being slashed, will it get to the ...

FDA approves Yeztugo HIV prevention injection showing 96% efficacy in clinical trials, but $14,000 cost creates significant ...

Learn more about lenacapavir, the most effective HIV treatment and prevention drug, and how its cost could cause a setback.

The US Food and Drug Administration on Wednesday approved Gilead Sciences' twice-yearly injection to prevent HIV – a move the ...

The Food and Drug Administration has approved lenacapavir, a breakthrough medication that reduces the risk of contracting HIV ...

The United States has approved a twice-a-year jab that almost entirely protects against HIV in what’s being hailed as a ...

A drug called lenacapavir, administered in two injections a year, offers protection from HIV comparable to daily pills. One ...

The breakthrough double injection won’t be cheap in the US, although scientists argue it could (and should) be.